Valneva SE (VALN) Other Non Operating Income (2021 - 2026)

Valneva SE (VALN) posted quarterly Other Non Operating Income of -$3.4 million for Q1 2026, down 181.42% year-on-year from $4.2 million in Q1 2025, and down 232.0% on a QoQ basis from -$1.0 million in Q4 2025.

Valneva SE (VALN) Other Non Operating Income (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Other Non Operating Income for 6 consecutive years, with -$3.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Other Non Operating Income fell 181.42% year-over-year to -$3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.8 million (down 247.71% YoY) and the FY2025 annual result came in at -$8.2 million, down 325.0% from the prior year.
  • Other Non Operating Income slipped to -$3.4 million in Q1 2026 per VALN's latest filing, from -$1.0 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for VALN reached as high as $15.8 million in Q4 2022 and fell as low as -$18.0 million in Q3 2022.
  • A 5-year average of -$937205.8 and a median of -$1.0 million in 2025 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income jumped 397.32% — and 2025, when it slumped 944.73%.
  • Year by year, Other Non Operating Income stood at $15.8 million in 2022, then sank by 49.55% to $8.0 million in 2023, then decreased by 11.62% to $7.1 million in 2024, then sank by 114.52% to -$1.0 million in 2025, then tumbled by 232.0% to -$3.4 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$3.4 million, -$1.0 million, and -$16.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.40 Mn
Dec 31, 2025 -1.02 Mn
Sep 30, 2025 -16.03 Mn
Jun 30, 2025 4.68 Mn
Mar 31, 2025 4.18 Mn
Dec 31, 2024 7.06 Mn
Sep 30, 2024 -1.53 Mn
Jun 30, 2024 978,640.67
Mar 31, 2024 -2.86 Mn
Dec 31, 2023 7.98 Mn
Sep 30, 2023 -6.78 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 3.61 Mn
Dec 31, 2022 15.82 Mn
Sep 30, 2022 -18.02 Mn
Jun 30, 2022 -9.38 Mn
Mar 31, 2022 -2.74 Mn
Dec 31, 2021 3.18 Mn
Sep 30, 2021 -3.87 Mn